Public trial registry of the CCC-Munich

Trial CLL 10

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CLL 10
World
Full title
:

Phase III trial of combined immunochemotherapy with Fludarabine, Cyclophosphamid and Rituximab (FCR) versus Bendamustine and Rituximab (BR) in patients with previously untreated chronic lymphocytic leukaemia

CAVE!!!! Patienten aus der CLL10 Studie gehen in das CLL Register, werden allerdings hier noch im Follow-up nachbeobachtet.

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 M√ľnchen Germany Tum
Indications
Classification Code Description
- C91.1 CLL
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Christian Bogner Keine Organisationseinheit angegeben Magnifier